Owner · Company
GlaxoSmithKline
GlaxoSmithKline operates 5 power plants in the United Kingdom.
Portfolio
The 5 assets and rights GlaxoSmithKline owns, operates or holds, by class, with its role in each, across its 4 records. Sizes are the whole asset's, so they are not added up: the sources give no share for this owner.
Power plants 5
| Power plant | Location | Role | Capacity |
|---|---|---|---|
| Glaxosmithkline Shewalton Road | North Ayrshire, Scotland, United Kingdom | Operator | 19.9 MW |
| GlaxoSmithKline Wind Project | North Ayrshire, Scotland, United Kingdom | Operator | 7.5 MW |
| Shewalton Road | North Ayrshire, Scotland, United Kingdom | Operator | 3 MW |
| GlaxoSmithKline Wind Project (Turbine 4) | North Ayrshire, Scotland, United Kingdom | Operator | 2.5 MW |
| GlaxoSmithKline (Waste AD) | North Ayrshire, Scotland, United Kingdom | Operator | 1 MW |
By country
Where the assets and rights are.
- The United Kingdom5 power plants
Latest events
Dated events about GlaxoSmithKline and its assets from official notices and registers, newest first: the latest 8 of 15. All recent changes.
- Construction started: Glaxosmithkline Shewalton Road
- Construction started: Shewalton Road
- Permit granted: Glaxosmithkline Shewalton Road (planning authority North Ayrshire, reference 19/00163/PP)
- Permit granted: Shewalton Road (planning authority North Ayrshire, reference 19/00164/PP)
- Permit applied for: Glaxosmithkline Shewalton Road (planning authority North Ayrshire, reference 19/00163/PP)
- Permit applied for: Shewalton Road (planning authority North Ayrshire, reference 19/00164/PP)
- Commissioned: GlaxoSmithKline (Waste AD)
- Commissioned: GlaxoSmithKline Wind Project (Turbine 4)
Group
Parent company
GlaxoSmithKline reports no parent company: no known owner (GLEIF LEI).
Facts
| Fact | Value | Source |
|---|---|---|
| Location | England | Companies House bulk company data · record · OGL v3 · checked 25 Oct 2026 |
| Location | United Kingdom | GLEIF LEI · record · CC0 1.0 · checked 25 Oct 2026 Wikidata · record · CC0 1.0 · checked 24 Oct 2026 |
| LEI | 5493000HZTVUYLO1D793 | Rare Context entity resolution · record · CC0 1.0 · checked 25 Oct 2026 GLEIF LEI · record · CC0 1.0 · checked 25 Oct 2026 Wikidata · record · CC0 1.0 · checked 24 Oct 2026 |
| Ticker | GSK (on London Stock Exchange) | Wikidata · record · CC0 1.0 · checked 24 Oct 2026 |
| Company number | 03888792 | Companies House bulk company data · record · OGL v3 · checked 25 Oct 2026 GLEIF LEI · record · CC0 1.0 · checked 25 Oct 2026 Wikidata · record · CC0 1.0 · checked 24 Oct 2026 |
| Also known as | SmithKline Beecham | Wikidata · record · CC0 1.0 · checked 24 Oct 2026 |
| Also known as | GlaxoSmithKline | Wikidata · record · CC0 1.0 · checked 24 Oct 2026 |
| Also known as | GSK plc | Wikidata · record · CC0 1.0 · checked 24 Oct 2026 |
| Also known as | Gsk | Wikidata · record · CC0 1.0 · checked 24 Oct 2026 |
| Also known as | Glaxo | Wikidata · record · CC0 1.0 · checked 24 Oct 2026 |
| Also known as | gsk | Wikidata · record · CC0 1.0 · checked 24 Oct 2026 |
| Also known as | Glaxo Smith Kline | Wikidata · record · CC0 1.0 · checked 24 Oct 2026 |
| Also known as | GlaxoSmithKline plc | Wikidata · record · CC0 1.0 · checked 24 Oct 2026 |
| Register status | Active | Companies House bulk company data · record · OGL v3 · checked 25 Oct 2026 |
| Company type | Public Limited Company | Companies House bulk company data · record · OGL v3 · checked 25 Oct 2026 |
| Incorporated | 6 Dec 1999 | Companies House bulk company data · record · OGL v3 · checked 25 Oct 2026 |
| Industry (SIC) | 70100 - Activities of head offices | Companies House bulk company data · record · OGL v3 · checked 25 Oct 2026 |
Also recorded as
Sources name GlaxoSmithKline under 4 records; this page joins them. Links to any of them lead here.
| Name in the source | Identifier | Source |
|---|---|---|
| GSK PLC | party:company-number:gb-03888792 | Companies House bulk company data |
| GSK PLC | party:lei:5493000HZTVUYLO1D793 | GLEIF LEI |
| GSK | party:wikidata:Q212322 | Wikidata |
| GlaxoSmithKline | party:name:glaxosmithkline | DESNZ Renewable Energy Planning Database (REPD) |
Research on GlaxoSmithKline.Its full portfolio, its parent companies, and an introduction to the people who decide on buying and selling.
Request researchData on this page
- Our public task, copyright and Crown copyright. Companies House bulk company data, OGL v3.
- Contains public sector information licensed under the Open Government Licence v3.0. DESNZ Renewable Energy Planning Database (REPD), Open Government Licence v3.0.
- GLEIF LEI. GLEIF LEI, CC0 1.0.
- Rare Context entity resolution. Rare Context entity resolution, CC0 1.0.
- Wikidata. Wikidata, CC0 1.0.